Prospective, Multicenter, Single-Arm Observational Study to Confirm the Safety and Clinical Performance of the Oscar Peripheral Multifunctional Catheter for the Dilatation of Lesions in the Femoral, Popliteal and Infrapopliteal Arteries (BIO-OSCAR First)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBiotronik AG

About this trial

The purpose of this study is to evaluate the standard of care practices, procedural outcomes, and in-hospital complications for endovascular peripheral interventions of femoral, popliteal and infrapopliteal lesions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Subject ≥18 years old

Subject has provided written informed consent

Subject has Rutherford classification 2 to 6

Reference vessel diameter ≥2 and ≤7 mm

Disqualifiers

Subject has a single target lesion that involves both ATK and BTK segments.

Subject not suitable for receiving endovascular procedures of lower limb arteries.

Prior planned major amputation in the target limb (i.e., above the ankle).

Subject with previous bypass surgery of target vessel.

Trial population

A total of 200 patients will be enrolled, with approximately 100 subjects in ATK group, and 100 subjects in BTK group.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Oscar Peripheral Multifunctional Catheter

    Device

    Oscar Peripheral Multifunctional Catheter encompasses three components: (i) Oscar Support Catheter with integrated Lock Grip, (ii) Oscar Dilator and (iii) Oscar PTA Balloon. Single Oscar PTA Balloon is also available separately and can only be used together with the pre-supplied Oscar Support Catheter as indicated in the compatibility chart in the Instructions for Use (IFU).

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Oscar Procedural success rate

combination of Oscar technical success and absence of serious procedural complications

Time frame
Index procedure

Secondary outcomes

1

Rate of (Serious) Adverse Device Effects (S)ADE

(Serious) Adverse Device Effects

Time frame
discharge (30 days)
2

Rate of distal embolization

Distal embolization

Time frame
Index procedure
3

Rate of target vessel rupture

Target vessel rupture

Time frame
Index procedure
4

Rate of target vessel perforation

Target vessel perforation

Time frame
Index procedure

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.